About
LivaNova PLC is a global medical technology company based in London, UK. Established in 2015 through a merger between Cyberonics, Inc. and Sorin S.p.A., LivaNova specializes in innovative medical devices and therapies for neurological and cardiac conditions. The company operates in two main segments: Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides a variety of products, including heart-lung machines and oxygenators, used in cardiac surgery. The Neuromodulation segment focuses on the Vagus Nerve Stimulation (VNS) Therapy System, which treats difficult-to-treat depression and drug-resistant epilepsy. LivaNova serves a diverse customer base, including healthcare providers and medical institutions, distributing its products in over 100 countries. With around 2,900 employees, LivaNova reported revenues of approximately $1.25 billion in 2024. The company is committed to high quality and ethical practices, aiming to improve patient outcomes through its advanced therapies for heart and brain conditions.
Technologies
Keywords
Company Information
- Employees2900
- Founded2015
- Annual Revenue$1253437000
- Total Funding$125000000
Location
20 Eastbourne Terrace, England, United Kingdom, W2 6LA
